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Single gene of 11 exons spanning 21 kbp. 
Transcription 
2.4 Kb mRNA; PDCD4 mRNA levels modulated by 







469 amino acids; 52 kDa predicted; found to be 50-64 
kDa in mouse and human tissues and cell lines; 
contains two highly conserved helical MA3 domains 
each about 130 amino acids long; contains two 
Akt/S6K phosphorylation sites, one N-terminal and one 
C-terminal; contains two nuclear export signals. 
Expression 
PDCD4 expressed in all tissues tested. Shows inverse 
expression with proliferation marker PCNA, higher 
expression in differentiated areas. Protein expression is 
regulated by PI3K/Akt/S6K and MEK/ERK signaling 
that programs PDCD4 for ubiquitylation and 
proteasome degradation. 
Localisation 
Nuclear and cytoplasmic. Inhibits translation in 
cytoplasm. 
Function 
PDCD4 inhibits translation initiation mRNA-
specifically by interacting with translation initiation 
factor eIF4A and competing with eIF4Gc for binding to 
eIF4A. As a consequence of inhibiting translation 
initiation, inhibits AP-1 dependent transcription via 
targeting Jun kinase signaling. Found to be a tumor 
suppressor in PDCD4 transgenic and deficient mice. 
Homology 
Conserved MA3 domain also found in translation 
initiation factor eIF4G, a scaffold protein; death 
associated protein DAP5; and NOM 1, a nucleolar 
protein. 
Mutations 





PDCD4 expression attenuated with progression in 
human tumors of the lung, colon, prostate and breast; 
diagnostic and prognostic for colon cancer staging with 
decreased expression in adenomas and a further 
decrease in stage 1 adenocarcinomas. Transgenic 
PDCD4 expression attenuates skin tumorigenesis and 
tumor progression in transgenic mice; PDCD4 
deficiency increases tumor multiplicity and tumor 
incidence. 
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